カテゴリー： GlobalInfoResearch, 世界

RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global RNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101166）・商品コード：GIR9101166
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月10日（※2024年版があります。お問い合わせください）
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・RNAワクチンの市場概観
・RNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・RNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向
・RNAワクチンの世界市場規模
・RNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等）
・RNAワクチンのアメリカ市場規模推移
・RNAワクチンのカナダ市場規模推移
・RNAワクチンのメキシコ市場規模推移
・RNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・RNAワクチンのドイツ市場規模推移
・RNAワクチンのイギリス市場規模推移
・RNAワクチンのロシア市場規模推移
・RNAワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・RNAワクチンの日本市場規模推移
・RNAワクチンの中国市場規模推移
・RNAワクチンの韓国市場規模推移
・RNAワクチンのインド市場規模推移
・RNAワクチンの東南アジア市場規模推移
・RNAワクチンの南米市場分析（ブラジル、アルゼンチン等）
・RNAワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・RNAワクチンの種類別分析/販売量、売上、市場シェア（個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）
・RNAワクチンの用途別分析/市場規模（感染症、がん、その他）
・RNAワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・RNAワクチンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

Scope of the Report:
The worldwide market for RNA Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the RNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Market Segment by Applications, can be divided into
Infectious Disease
Cancer
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of RNA Vaccines, with price, sales, revenue and global market share of RNA Vaccines in 2017 and 2018.
Chapter 3, the RNA Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, RNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe RNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 RNA Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Individualized Cancer Treatment MRNA Vaccine
1.2.2 Infectious Disease Treatment MRNA Vaccine
1.2.3 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Applications
1.3.1 Infectious Disease
1.3.2 Cancer
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Business Overview
2.1.2 RNA Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 CureVac
2.2.1 Business Overview
2.2.2 RNA Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CureVac RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Translate Bio
2.3.1 Business Overview
2.3.2 RNA Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Translate Bio RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 BioNTech
2.4.1 Business Overview
2.4.2 RNA Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioNTech RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.2 RNA Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Argos Therapeutics
2.6.1 Business Overview
2.6.2 RNA Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Argos Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 In-Cell-Art
2.7.1 Business Overview
2.7.2 RNA Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 In-Cell-Art RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 eTheRNA
2.8.1 Business Overview
2.8.2 RNA Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 eTheRNA RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Ethris
2.9.1 Business Overview
2.9.2 RNA Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ethris RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tiba Biotechnology
2.10.1 Business Overview
2.10.2 RNA Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global RNA Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global RNA Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global RNA Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 RNA Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 RNA Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global RNA Vaccines Market Analysis by Regions
4.1 Global RNA Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global RNA Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global RNA Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America RNA Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe RNA Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific RNA Vaccines Sales and Growth Rate (2014-2019)
4.5 South America RNA Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa RNA Vaccines Sales and Growth Rate (2014-2019)
5 North America RNA Vaccines by Country
5.1 North America RNA Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America RNA Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America RNA Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States RNA Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada RNA Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico RNA Vaccines Sales and Growth Rate (2014-2019)
6 Europe RNA Vaccines by Country
6.1 Europe RNA Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe RNA Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe RNA Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany RNA Vaccines Sales and Growth Rate (2014-2019)
6.3 UK RNA Vaccines Sales and Growth Rate (2014-2019)
6.4 France RNA Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia RNA Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy RNA Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific RNA Vaccines by Country
7.1 Asia-Pacific RNA Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific RNA Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific RNA Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China RNA Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan RNA Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea RNA Vaccines Sales and Growth Rate (2014-2019)
7.5 India RNA Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia RNA Vaccines Sales and Growth Rate (2014-2019)
8 South America RNA Vaccines by Country
8.1 South America RNA Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America RNA Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America RNA Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil RNA Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina RNA Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia RNA Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa RNA Vaccines by Countries
9.1 Middle East and Africa RNA Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa RNA Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa RNA Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia RNA Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey RNA Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt RNA Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria RNA Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa RNA Vaccines Sales and Growth Rate (2014-2019)
10 Global RNA Vaccines Market Segment by Type
10.1 Global RNA Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global RNA Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global RNA Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price
10.2.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)
10.2.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)
10.3 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price
10.3.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)
10.3.2 Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)
10.4 Infection Prevention MRNA Vaccine Sales Growth and Price
10.4.1 Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)
10.4.2 Global Infection Prevention MRNA Vaccine Price (2014-2019)
11 Global RNA Vaccines Market Segment by Application
11.1 Global RNA Vaccines Sales Market Share by Application (2014-2019)
11.2 Infectious Disease Sales Growth (2014-2019)
11.3 Cancer Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 RNA Vaccines Market Forecast (2019-2024)
12.1 Global RNA Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 RNA Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America RNA Vaccines Market Forecast (2019-2024)
12.2.2 Europe RNA Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific RNA Vaccines Market Forecast (2019-2024)
12.2.4 South America RNA Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa RNA Vaccines Market Forecast (2019-2024)
12.3 RNA Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global RNA Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global RNA Vaccines Market Share Forecast by Type (2019-2024)
12.4 RNA Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global RNA Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global RNA Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure RNA Vaccines Picture
Table Product Specifications of RNA Vaccines
Figure Global Sales Market Share of RNA Vaccines by Types in 2018
Table RNA Vaccines Types for Major Manufacturers
Figure Individualized Cancer Treatment MRNA Vaccine Picture
Figure Infectious Disease Treatment MRNA Vaccine Picture
Figure Infection Prevention MRNA Vaccine Picture
Figure RNA Vaccines Sales Market Share by Applications in 2018
Figure Infectious Disease Picture
Figure Cancer Picture
Figure Other Picture
Figure United States RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure France RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure UK RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure China RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure India RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria RNA Vaccines Revenue (Value) and Growth Rate (2014-2024)
Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Moderna Therapeutics RNA Vaccines Type and Applications
Table Moderna Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CureVac Basic Information, Manufacturing Base and Competitors
Table CureVac RNA Vaccines Type and Applications
Table CureVac RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Translate Bio Basic Information, Manufacturing Base and Competitors
Table Translate Bio RNA Vaccines Type and Applications
Table Translate Bio RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BioNTech Basic Information, Manufacturing Base and Competitors
Table BioNTech RNA Vaccines Type and Applications
Table BioNTech RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics RNA Vaccines Type and Applications
Table Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table Argos Therapeutics RNA Vaccines Type and Applications
Table Argos Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table In-Cell-Art RNA Vaccines Type and Applications
Table In-Cell-Art RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table eTheRNA Basic Information, Manufacturing Base and Competitors
Table eTheRNA RNA Vaccines Type and Applications
Table eTheRNA RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ethris Basic Information, Manufacturing Base and Competitors
Table Ethris RNA Vaccines Type and Applications
Table Ethris RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table Tiba Biotechnology RNA Vaccines Type and Applications
Table Tiba Biotechnology RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global RNA Vaccines Sales by Manufacturer (2017-2018)
Figure Global RNA Vaccines Sales Market Share by Manufacturer in 2017
Figure Global RNA Vaccines Sales Market Share by Manufacturer in 2018
Table Global RNA Vaccines Revenue by Manufacturer (2017-2018)
Figure Global RNA Vaccines Revenue Market Share by Manufacturer in 2017
Figure Global RNA Vaccines Revenue Market Share by Manufacturer in 2018
Figure Top 3 RNA Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 RNA Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Global RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Global RNA Vaccines Revenue and Growth Rate (2014-2019)
Table Global RNA Vaccines Sales by Regions (2014-2019)
Table Global RNA Vaccines Sales Market Share by Regions (2014-2019)
Table Global RNA Vaccines Revenue by Regions (2014-2019)
Figure Global RNA Vaccines Revenue Market Share by Regions in 2014
Figure Global RNA Vaccines Revenue Market Share by Regions in 2018
Figure North America RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Europe RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific RNA Vaccines Sales and Growth Rate (2014-2019)
Figure South America RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa RNA Vaccines Sales and Growth Rate (2014-2019)
Figure North America RNA Vaccines Revenue and Growth Rate (2014-2019)
Table North America RNA Vaccines Sales by Countries (2014-2019)
Table North America RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure North America RNA Vaccines Sales Market Share by Countries in 2014
Figure North America RNA Vaccines Sales Market Share by Countries in 2018
Table North America RNA Vaccines Revenue by Countries (2014-2019)
Table North America RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America RNA Vaccines Revenue Market Share by Countries in 2014
Figure North America RNA Vaccines Revenue Market Share by Countries in 2018
Figure United States RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Canada RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Mexico RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Europe RNA Vaccines Revenue and Growth Rate (2014-2019)
Table Europe RNA Vaccines Sales by Countries (2014-2019)
Table Europe RNA Vaccines Sales Market Share by Countries (2014-2019)
Table Europe RNA Vaccines Revenue by Countries (2014-2019)
Figure Europe RNA Vaccines Revenue Market Share by Countries in 2017
Figure Europe RNA Vaccines Revenue Market Share by Countries in 2018
Figure Germany RNA Vaccines Sales and Growth Rate (2014-2019)
Figure UK RNA Vaccines Sales and Growth Rate (2014-2019)
Figure France RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Russia RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Italy RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific RNA Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific RNA Vaccines Sales by Countries (2014-2019)
Table Asia-Pacific RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific RNA Vaccines Sales Market Share by Countries 2018
Table Asia-Pacific RNA Vaccines Revenue by Countries (2014-2019)
Figure Asia-Pacific RNA Vaccines Revenue Market Share by Countries 2018
Figure China RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Japan RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Korea RNA Vaccines Sales and Growth Rate (2014-2019)
Figure India RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Southeast Asia RNA Vaccines Sales and Growth Rate (2014-2019)
Figure South America RNA Vaccines Revenue and Growth Rate (2014-2019)
Table South America RNA Vaccines Sales by Countries (2014-2019)
Table South America RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure South America RNA Vaccines Sales Market Share by Countries in 2018
Table South America RNA Vaccines Revenue by Countries (2014-2019)
Table South America RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America RNA Vaccines Revenue Market Share by Countries in 2018
Figure Brazil RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Argentina RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Colombia RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa RNA Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa RNA Vaccines Sales by Countries (2014-2019)
Table Middle East and Africa RNA Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa RNA Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa RNA Vaccines Revenue by Countries (2014-2019)
Table Middle East and Africa RNA Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa RNA Vaccines Revenue Market Share by Countries in 2014
Figure Middle East and Africa RNA Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia RNA Vaccines Sales and Growth Rate (2014-2019)
Figure UAE RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Egypt RNA Vaccines Sales and Growth Rate (2014-2019)
Figure Nigeria RNA Vaccines Sales and Growth Rate (2014-2019)
Figure South Africa RNA Vaccines Sales and Growth Rate (2014-2019)
Table Global RNA Vaccines Sales by Type (2014-2019)
Table Global RNA Vaccines Sales Share by Type (2014-2019)
Table Global RNA Vaccines Revenue by Type (2014-2019)
Table Global RNA Vaccines Revenue Share by Type (2014-2019)
Figure Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2014-2019)
Figure Global Individualized Cancer Treatment MRNA Vaccine Price (2014-2019)
Figure Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2014-2019)
Figure Global Infectious Disease Treatment MRNA Vaccine Price (2014-2019)
Figure Global Infection Prevention MRNA Vaccine Sales Growth (2014-2019)
Figure Global Infection Prevention MRNA Vaccine Price (2014-2019)
Table Global RNA Vaccines Sales by Application (2014-2019)
Table Global RNA Vaccines Sales Share by Application (2014-2019)
Figure Global Cancer Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global RNA Vaccines Sales, Revenue and Growth Rate (2019-2024)
Table Global RNA Vaccines Sales Forecast by Regions (2019-2024)
Table Global RNA Vaccines Market Share Forecast by Regions (2019-2024)
Figure North America Sales RNA Vaccines Market Forecast (2019-2024)
Figure Europe Sales RNA Vaccines Market Forecast (2019-2024)
Figure Asia-Pacific Sales RNA Vaccines Market Forecast (2019-2024)
Figure South America Sales RNA Vaccines Market Forecast (2019-2024)
Figure Middle East and Africa Sales RNA Vaccines Market Forecast (2019-2024)
Table Global RNA Vaccines Sales Forecast by Type (2019-2024)
Table Global RNA Vaccines Market Share Forecast by Type (2019-2024)
Table Global RNA Vaccines Sales Forecast by Application (2019-2024)
Table Global RNA Vaccines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology、

★調査レポート[RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101166)販売に関する免責事項を必ずご確認ください。
★調査レポート[RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 猫用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101182 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、猫用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、＜6ヶ月、≥6ヶ月等に区分しました。猫用ワクチンの世界市場概観、メーカー動向、メーカー別猫用ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・猫用ワクチンの市場概観 ・猫用ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・猫用ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・猫用ワクチンの世界市場規模 ・猫用ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・猫用ワクチンのアメリカ市場規模推移 ・猫用ワクチンのカナダ市場規模推移 ・猫用ワクチンのメキシコ市場規模推移 ・猫用ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for cats Scope of the Report: The worldwide market for Cat Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 犬用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101183 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、犬用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs Scope of the Report: The worldwide market for Dog Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 新興癌ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103455 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、新興癌ワクチンの世界市場について調べ、まとめました。種類別セグメントは、非遺伝子ワクチン、遺伝子ワクチン等、用途別セグメントは、がん研究センター、がん病院、クリニック、その他等に区分しました。新興癌ワクチンの世界市場概観、メーカー動向、メーカー別新興癌ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・新興癌ワクチンの市場概観 ・新興癌ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・新興癌ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・新興癌ワクチンの世界市場規模 ・新興癌ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・新興癌ワクチンのアメリカ市場規模推移 ・新興癌ワクチンのカナダ市場規模推移 ・新興癌ワクチンのメキシコ市場規模推移 ・新興癌ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens. Scope of the Report: The worldwide market for Emerging Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Emerging Cancer Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and...
  • 小児ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100436 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、小児ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他等、用途別セグメントは、病院、クリニック等に区分しました。小児ワクチンの世界市場概観、メーカー動向、メーカー別小児ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児ワクチンの市場概観 ・小児ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・小児ワクチンの世界市場規模 ・小児ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・小児ワクチンのアメリカ市場規模推移 ・小児ワクチンのカナダ市場規模推移 ・小児ワクチンのメキシコ市場規模推移 ・小児ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers MedImmune LLC J&J(Crucell) Pfizer Sanofi GSK Merck Tiantan CSL Jintan...
  • オーエスキー病ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100289 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オーエスキー病ワクチンの市場概観 ・オーエスキー病ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オーエスキー病ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・オーエスキー病ワクチンの世界市場規模 ・オーエスキー病ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・オーエスキー病ワクチンのアメリカ市場規模推移 ・オーエスキー病ワクチンのカナダ市場規模推移 ・オーエスキー病ワクチンのメキシコ市場規模推移 ・オーエスキー病ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Aujeszky Disease Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Aujeszky Disease Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Zendal group(CZ Vaccines) Kyoritsuseiyaku Corporation Ceva IDEXX MSD Animal...

    • ◆H&Iグローバルリサーチのお客様（例）◆